PDAC 2023: The World’s Premier Mineral Exploration & Mining Convention is the leading event for people, companies and organizations connected to mineral exploration.

This annual convention in Toronto attracts thousands of attendees from over 130+ countries for its educational programming, networking events, outstanding business opportunities and fun.

The PDAC Convention is the event of choice for the world’s mineral industry hosting more than 1,100 exhibitors and 2,500 investors.

Tectonic Metals: Director of Investor Relations – Bill Stormont

Back to top


Osisko Metals: CEO – Robert Wares

Back to top


Brunswick Exploration: President & CEO – Killian Charles

Back to top


Orford Mining: President, CEO and Director – David Christie

Back to top

Millennial Potash: Chairman – Farhad Abasov

Back to top


Silver Hammer Mining: CEO – Peter Ball

Back to top


Electro Metals & Mining: CEO – Daryl Hodges

Back to top


International Lithium Corp: CEO – John Wisbey

Back to top


Green Shift Commodities: CEO – Trumbull Fisher

Back to top


Monument Mining: President & CEO – Cathy Zhai

Back to top


Dolly Varden Silver Corp: CEO – Shawn Khunkhun

Back to top


Northern Graphite Corporation: CEO – Hugues Jacquemin

Back to top


High Tide Resources: Etienn Gouin-Proulx

Back to top


Avino Silver & Gold Mines: President & CEO – David Wolfin

Back to top


Outcrop Silver & Gold Corp: CEO – Joseph Hebert

Back to top


iMetal Resources: CEO – Saf Dhillon

Back to top


Golden Cariboo Resources: Director – Andrew Rees

Back to top


Lithium One Environmental: CEO – David Stevenson

Back to top


CSE: CEO – Richard Carleton

Back to top


Rock Tech Lithium: Chairman and CEO – Dirk Harbecke

Back to top


S&P Global Market Intelligence: Principal Analyst and Head of Mine Economics – Kevin Murphy

Back to top


Matador Gold Technologies: CEO – Deven Soni

Back to top


Palladium One Mining: VP Exploration – Neil Pettigrew

Back to top


Exploration Insights: Editor/Analyst – Joe Mazumdar

Back to top


Silver Bullet Mines: VP Capital Markets – Peter Clausi

Back to top


CanAlaska Uranium Ltd: CEO & Director – Cory Belyk

Back to top


Avrupa Minerals: President & CEO – Paul Kuhn

Back to top


EV Nickel: CEO – Sean Samson

Back to top


Moneta Gold: CEO – Gary O’Connor

Back to top


Geodrill: President & CEO – Dave Harper

Back to top


Arras Minerals Corp: CEO – Tim Barry

Back to top


De Beers Group: Managing Director, Managed Operations – Moses Madondo

Back to top


Standard Uranium Ltd: CEO & Director – Jon Bey

Back to top

Phenom Resources: President & CEO – Paul Cowley, P.Geo

Back to top


The Red Rock Indian Band: Chief Marcus Hardy

Back to top


Focus Graphite: CEO – Marc Roy

Back to top


Big Gold Inc: President & CEO – Scott Walters

Back to top


Murchison Minerals: President & CEO – Troy Boisjoli

Back to top


Lahontan Gold: CEO – Kimberly Ann

Back to top


Intrepid Metals: CEO – Ken Brophy

Back to top


Cornish Metals: President & CEO – Richard Williams

Back to top


MacArthur Minerals: Executive Chairman & CEO – Cameron McCall

Back to top


MKS PAMP: Head of Metals Strategy – Nicky Shiels

Back to top


Cassiar Gold Corp: President & CEO – Marco Roque

Back to top


Montt Group: Principal CEO – Santiago Montt

Back to top


RK Equity Advisors: Founder & Partner – Howard Klein

Back to top


Battery Age Minerals: CEO – Gerard O’Donovan

Back to top

More From The Market Online
Docebo Inc. - CEO, Claudio Erba

Docebo stock rallies on 2023 financial report

Software firm Docebo (TSX:DCBO) reported its Q4 and fiscal year 2023 financial results above analysts’ estimates.

FaZe Clan stockholders approve GameSquare merger

FaZe Holdings Inc. (NASDAQ:FAZE) announced that its stockholders have voted to approve the proposed merger with GameSquare (NASDAQ:GAME).

Zonte Metals discovers large copper-in-soil anomalies in Newfoundland

Zonte Metals (TSXV:ZON) has discovered copper-in-soil anomalies at its Cross Hills Copper Project in Newfoundland.

Clearmind Medicine to begin alcohol use disorder clinical trial

Clearmind Medicine (CSE:CMND) has received approval to begin its phase I/IIa clinical trial for alcohol use disorder in Israel.